RU2523543C2 - Соли производных тетерагидро-имидазо[1,5-a]пиразина, способы их получения и их медицинское применение - Google Patents

Соли производных тетерагидро-имидазо[1,5-a]пиразина, способы их получения и их медицинское применение Download PDF

Info

Publication number
RU2523543C2
RU2523543C2 RU2011137858/04A RU2011137858A RU2523543C2 RU 2523543 C2 RU2523543 C2 RU 2523543C2 RU 2011137858/04 A RU2011137858/04 A RU 2011137858/04A RU 2011137858 A RU2011137858 A RU 2011137858A RU 2523543 C2 RU2523543 C2 RU 2523543C2
Authority
RU
Russia
Prior art keywords
salt
trifluorophenyl
trifluoromethyl
butanoyl
amino
Prior art date
Application number
RU2011137858/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2011137858A (ru
Inventor
Пэн Чо ТАН
Пяоян СУНЬ
Фанлон ЯН
Цзиньдун ЛЯН
Гуанюань ШЭНЬ
Ян ВАН
Цзян ФАНЬ
Original Assignee
Цзянсу Хэнжуй Медицин Ко., Лтд.
Шанхай Хэнжуй Фармасьютикал Со., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Цзянсу Хэнжуй Медицин Ко., Лтд., Шанхай Хэнжуй Фармасьютикал Со., Лтд. filed Critical Цзянсу Хэнжуй Медицин Ко., Лтд.
Publication of RU2011137858A publication Critical patent/RU2011137858A/ru
Application granted granted Critical
Publication of RU2523543C2 publication Critical patent/RU2523543C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2011137858/04A 2009-03-05 2010-03-03 Соли производных тетерагидро-имидазо[1,5-a]пиразина, способы их получения и их медицинское применение RU2523543C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200910047075A CN101824036A (zh) 2009-03-05 2009-03-05 四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用
CN200910047075.4 2009-03-05
PCT/CN2010/000257 WO2010099698A1 (zh) 2009-03-05 2010-03-03 四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用

Publications (2)

Publication Number Publication Date
RU2011137858A RU2011137858A (ru) 2013-04-10
RU2523543C2 true RU2523543C2 (ru) 2014-07-20

Family

ID=42688223

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011137858/04A RU2523543C2 (ru) 2009-03-05 2010-03-03 Соли производных тетерагидро-имидазо[1,5-a]пиразина, способы их получения и их медицинское применение

Country Status (12)

Country Link
US (1) US8518946B2 (cg-RX-API-DMAC7.html)
EP (1) EP2404921B1 (cg-RX-API-DMAC7.html)
JP (1) JP5976322B2 (cg-RX-API-DMAC7.html)
KR (1) KR101731602B1 (cg-RX-API-DMAC7.html)
CN (2) CN101824036A (cg-RX-API-DMAC7.html)
AU (1) AU2010220722B2 (cg-RX-API-DMAC7.html)
CA (1) CA2753862C (cg-RX-API-DMAC7.html)
MX (1) MX2011009190A (cg-RX-API-DMAC7.html)
RU (1) RU2523543C2 (cg-RX-API-DMAC7.html)
UA (1) UA106225C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010099698A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201107284B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2797922C2 (ru) * 2017-07-14 2023-06-13 Ф. Хоффманн-Ля Рош Аг Бициклические кетоны и способы их применения

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899048B (zh) * 2009-05-27 2013-04-17 上海恒瑞医药有限公司 (R)-7-[3-氨基-4-(2,4,5-三氟-苯基)-丁酰]-3-三氟甲基-5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸甲酯的盐
CN106892926B (zh) * 2012-10-16 2019-09-06 江苏盛迪医药有限公司 一种dpp-iv抑制剂的中间体、其制备方法和通过其制备dpp-iv抑制剂的方法
CN103664962A (zh) * 2013-12-20 2014-03-26 南京华威医药科技开发有限公司 哌嗪类衍生物
CN103910734B (zh) * 2014-03-28 2016-01-13 南京华威医药科技开发有限公司 一种具有哌嗪结构的dpp-4抑制剂
CN114702495A (zh) 2015-11-20 2022-07-05 福马治疗有限公司 作为泛素-特异性蛋白酶1抑制剂的嘌呤酮
CN119613408A (zh) 2017-07-14 2025-03-14 豪夫迈·罗氏有限公司 二环酮化合物及其使用方法
MX2020003451A (es) 2017-10-31 2020-08-03 Hoffmann La Roche Sulfonas y sulfoxidos biciclicos y metodos de uso de los mismos.
WO2020139988A1 (en) * 2018-12-28 2020-07-02 Forma Therapeutics, Inc. Compositions for inhibiting ubiquitin specific protease 1
CN113620957B (zh) * 2020-05-08 2022-04-19 盛世泰科生物医药技术(苏州)有限公司 一种胺甲基吡嗪类化合物的制备方法
CN113773323B (zh) * 2020-06-10 2023-05-12 江苏恒瑞医药股份有限公司 3r-氨基取代丁酰胺衍生物的制备方法
CN113880825B (zh) * 2020-07-01 2025-03-14 浙江海正药业股份有限公司 四氢异喹啉类衍生物的盐、其制备方法及其医药应用
JP2024504328A (ja) * 2021-01-21 2024-01-31 ザ スクリプス リサーチ インスティテュート 肺疾患の治療のための肺胞2型細胞増殖の小分子調節因子
CN114057751B (zh) * 2022-01-17 2022-04-12 盛世泰科生物医药技术(苏州)有限公司 一种dpp-iv抑制剂及其关键中间体的制备方法
CN115583935A (zh) * 2022-11-03 2023-01-10 浙江工业大学 一种4-(2,4,5-三氟苯基)-3-氧丁酸酯的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2268889C2 (ru) * 1998-07-08 2006-01-27 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (Скрас) Применение производных цистеина для получения лекарственного средства, предназначенного для лечения патологий, возникающих вследствие образования гетеротримерного протеина g

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6110949A (en) 1999-06-24 2000-08-29 Novartis Ag N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
CN101468988A (zh) 2007-12-26 2009-07-01 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2268889C2 (ru) * 1998-07-08 2006-01-27 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (Скрас) Применение производных цистеина для получения лекарственного средства, предназначенного для лечения патологий, возникающих вследствие образования гетеротримерного протеина g

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2797922C2 (ru) * 2017-07-14 2023-06-13 Ф. Хоффманн-Ля Рош Аг Бициклические кетоны и способы их применения

Also Published As

Publication number Publication date
US8518946B2 (en) 2013-08-27
CN102159578B (zh) 2013-04-10
KR101731602B1 (ko) 2017-04-28
RU2011137858A (ru) 2013-04-10
EP2404921A1 (en) 2012-01-11
AU2010220722A2 (en) 2011-11-03
AU2010220722A1 (en) 2011-10-27
CA2753862A1 (en) 2010-09-10
EP2404921A4 (en) 2012-08-15
US20120065209A1 (en) 2012-03-15
HK1154574A1 (en) 2012-04-27
CN101824036A (zh) 2010-09-08
ZA201107284B (en) 2012-12-27
WO2010099698A1 (zh) 2010-09-10
AU2010220722B2 (en) 2015-05-07
KR20110132561A (ko) 2011-12-08
UA106225C2 (ru) 2014-08-11
CN102159578A (zh) 2011-08-17
MX2011009190A (es) 2011-09-26
JP2012519193A (ja) 2012-08-23
EP2404921B1 (en) 2017-11-22
JP5976322B2 (ja) 2016-08-23
CA2753862C (en) 2017-05-23

Similar Documents

Publication Publication Date Title
CA2753862C (en) Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives salts, preparation methods and medicinal use thereof
JP2012519193A5 (cg-RX-API-DMAC7.html)
EP3983384B1 (en) N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis
RU2447063C2 (ru) Производные азабициклооктана, способ их получения и их применения в качестве ингибиторов дипептидилпептидазы iv
EP2230241B1 (en) Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof
US12344584B2 (en) KCNQ potentiators
CA3100795A1 (en) Pyridinyl and pyrazinyl-(aza)indolsulfonamides
KR20150003875A (ko) 바독솔론 메틸의 2,2-다이플루오로프로피온아미드 유도체, 그의 다형태 및 사용 방법
KR20210102887A (ko) 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
KR101682427B1 (ko) 통증 및 기타 질병을 치료하기 위한 화합물 및 방법
TWI522358B (zh) 四氫咪唑并〔1,5-a〕吡衍生物的鹽,其製備方法及其在醫藥上的應用
WO2008148279A1 (en) Cyclobutyl-fused pyrrolidine derivatives, their preparation methods and their medical use
HK1154574B (en) Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof
HK40068179B (en) 1-((2-(2,2,2-trifluoroethoxy)pyridin-4-yl)methyl)urea derivatives as kcnq potentiators
HK40068179A (en) 1-((2-(2,2,2-trifluoroethoxy)pyridin-4-yl)methyl)urea derivatives as kcnq potentiators
HK1134817B (en) Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180304